| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00B | 962.51M | 541.65M | 537.99M | 271.99M | 124.23M |
| Gross Profit | 241.36M | 228.57M | 123.56M | 115.94M | 61.92M | 34.20M |
| EBITDA | 189.91M | 163.86M | 77.86M | 89.69M | 22.93M | 20.17M |
| Net Income | 44.33M | 23.26M | 13.53M | 31.24M | -7.56M | 6.51M |
Balance Sheet | ||||||
| Total Assets | 2.23B | 2.15B | 1.02B | 966.93M | 769.32M | 257.22M |
| Cash, Cash Equivalents and Short-Term Investments | 172.77M | 131.36M | 55.87M | 68.62M | 69.92M | 27.45M |
| Total Debt | 671.15M | 641.83M | 238.30M | 262.48M | 233.92M | 71.30M |
| Total Liabilities | 1.45B | 1.39B | 500.38M | 497.08M | 358.16M | 133.66M |
| Stockholders Equity | 748.21M | 724.77M | 500.74M | 458.12M | 400.26M | 123.56M |
Cash Flow | ||||||
| Free Cash Flow | 23.24M | 42.01M | 9.08M | 35.01M | 6.92M | 21.86M |
| Operating Cash Flow | 93.07M | 117.02M | 52.12M | 87.73M | 29.54M | 28.47M |
| Investing Cash Flow | -32.35M | -584.63M | -64.56M | -85.53M | -375.16M | -14.06M |
| Financing Cash Flow | -39.58M | 547.89M | 957.00K | 2.88M | 388.54M | 3.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.33B | 29.78 | 6.07% | ― | 32.27% | ― | |
70 Outperform | £1.20B | 13.31 | 7.90% | 4.27% | 7.83% | -7.40% | |
65 Neutral | £436.92M | 18.72 | 3.57% | 4.39% | 1.31% | 10.19% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | £77.66M | 15.09 | 5.71% | 4.98% | -0.29% | -33.41% | |
60 Neutral | £378.68M | 24.64 | 7.03% | 2.12% | 15.99% | 96.05% | |
57 Neutral | £543.87M | 45.19 | 3.10% | 2.40% | 5.58% | 66.49% |
SigmaRoc PLC reported a strong performance in Q3 2025, with a 6% year-on-year increase in revenue to £775 million and a 17% rise in underlying EBITDA to £192.9 million. The company has shown resilience in challenging markets by leveraging synergies and cost management strategies, maintaining confidence in meeting full-year expectations. Despite some market weaknesses, SigmaRoc’s proactive measures and strategic positioning are expected to support continued growth, with optimism for an improved construction outlook and potential benefits from European stimulus programs.
The most recent analyst rating on (GB:SRC) stock is a Hold with a £115.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.
SigmaRoc reported a strong Q3 performance with a 6% increase in revenue and a 17% rise in underlying EBITDA, driven by effective synergy programs and cost management. The company remains optimistic about its full-year performance, despite market challenges, and anticipates improved demand in the construction sector due to European stimulus programs, which could enhance its market position.
The most recent analyst rating on (GB:SRC) stock is a Hold with a £115.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.
SigmaRoc announced an update regarding its AMeLi project, a joint venture with ArcelorMittal to develop net-zero CO2 lime kilns in Dunkirk. ArcelorMittal has expressed concerns over the project’s execution, particularly regarding French building permits, and has decided to step back. Despite this, SigmaRoc’s financial forecasts and medium-term targets remain unchanged, with no immediate impact on its operations or CO2 ambitions.
The most recent analyst rating on (GB:SRC) stock is a Buy with a £128.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.
SigmaRoc reported strong financial results for the first half of 2025, with a 13.4% increase in revenue and a 36.9% rise in EBITDA compared to the previous year. Despite challenging market conditions, the company achieved record underlying earnings per share and improved its financial position with effective cash management and reduced net debt. Strategic initiatives, including synergy programs and asset divestments, contributed to operational efficiency. The company remains optimistic about future growth, supported by expected infrastructure spending in Germany and increased European defense budgets.
The most recent analyst rating on (GB:SRC) stock is a Buy with a £128.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.
SigmaRoc reported a strong performance in the first half of 2025, with revenues increasing by 13% to £510 million and underlying EBITDA rising by 22% to £118 million. Despite challenges such as reduced core volumes due to market softness and external factors, the company maintained its margin strategy through active mix optimization and plant utilization. The company remains confident in its full-year outlook, driven by synergy initiatives and cost control, and anticipates further benefits as market conditions improve.
The most recent analyst rating on (GB:SRC) stock is a Buy with a £115.00 price target. To see the full list of analyst forecasts on SigmaRoc stock, see the GB:SRC Stock Forecast page.